The compounding pharmacies originally were supposed to provide customized medication for individual patients but have morphed into bulk manufacturers outside of FDA’s regulatory reach.

At the heart of the tragedy is the compounders’ successful track record blocking FDA authority that could have averted the disaster. Their efforts are a textbook model of industry opposition to new rules that could save lives. Their arguments are the same that the Chamber of Commerce and industry are using today to block clean air,